Exogenous Transforming Growth Factor-β in Brain-Induced Symptoms of Central Fatigue and Suppressed Dopamine Production in Mice
Open Access
- 4 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5), 2580
- https://doi.org/10.3390/ijms22052580
Abstract
Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is one of the most refractory diseases in humans and is characterized by severe central fatigue accompanied with various symptoms that affect daily life, such as impaired memory, depression, and somatic pain. However, the etiology and pathophysiological mechanisms of CFS remain unknown. To investigate the pathophysiological role of transforming growth factor (TGF)-β1, we injected a cytokine into the lateral ventricle of a C57BL/6 mouse. The intracranial injection of TGF-β1 increased the immobility duration in a forced swimming test (FST) and time spent at the closed arm in elevated plus maze (EPM) analysis. The mice injected with TGF-β1 into their brain showed increased sensitivity to pain in a von Frey test, and had a decreased retention time on rotarod and latency time in a bright box in a passive avoidance test. In addition, the serum levels of muscle fatigue biomarkers, lactate dehydrogenase (LDH) and creatine kinase (CK), were significantly increased after administration of TGF-β1. Intracranial injection of TGF-β1 significantly reduced the production of tyrosine hydroxylase (TH) in the ventral tegmental area, accompanied by a decreased level of dopamine in the striatum. The suppression of TH expression by TGF-β1 was confirmed in the human neuroblastoma cell line, SH-SY5Y. These results, which show that TGF-β1 induced fatigue-like behaviors by suppressing dopamine production, suggest that TGF-β1 plays a critical role in the development of central fatigue and is, therefore, a potential therapeutic target of the disease.This publication has 35 references indexed in Scilit:
- Potential causal factors of CFS/ME: a concise and systematic scoping review of factors researchedJournal of Translational Medicine, 2020
- Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)Journal of Translational Medicine, 2020
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive ReviewDiagnostics, 2019
- Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case–control studyClinical and Experimental Immunology, 2017
- Cytokine signature associated with disease severity in chronic fatigue syndrome patientsProceedings of the National Academy of Sciences of the United States of America, 2017
- Chronic fatigue syndrome and the immune system: Where are we now?Neurophysiologie Clinique/Clinical Neurophysiology, 2017
- Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET StudyJournal of Nuclear Medicine, 2014
- Mitochondrial dysfunctions in Myalgic Encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathwaysMetabolic Brain Disease, 2013
- Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic EncephalomyelitisJournal of Translational Medicine, 2011
- High levels of type 2 cytokine-producing cells in chronic fatigue syndromeClinical and Experimental Immunology, 2004